[NKTR] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -129.56%
YoY- -51.58%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 21,639 21,594 24,822 23,647 50,573 28,222 38,018 -8.95%
PBT -36,837 -137,081 -90,267 -122,875 -138,451 -119,495 -95,527 -14.67%
Tax -35 -63 126 92 200 -983 265 -
NP -36,802 -137,018 -90,393 -122,967 -138,651 -118,512 -95,792 -14.72%
Tax Rate - - - - - - - -
Total Cost 58,441 158,612 115,215 146,614 189,224 146,734 133,810 -12.88%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -170.07 -634.52 -364.16 -520.01 -274.16 -419.93 -251.96 -6.33%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.19 -0.73 -0.49 -0.68 -0.78 -0.68 -0.60 -17.42%
EPS Diluted -0.19 -0.73 -0.49 -0.68 -0.78 -0.68 -0.60 -17.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.